Pharvaris N.V.
PHVS
$31.60
$0.010.03%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -46.84% | 5.32% | -61.30% | -60.33% | -5.10% |
| Total Depreciation and Amortization | 25.88% | 156.58% | 58.19% | 53.89% | 36.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 199.08% | -50.93% | 4,977.48% | 366.56% | -154.95% |
| Change in Net Operating Assets | 35.80% | 241.70% | 95.33% | -236.05% | 197.77% |
| Cash from Operations | -18.58% | 1.95% | -14.19% | -53.90% | -45.36% |
| Capital Expenditure | 98.95% | 93.50% | 143.75% | -408.71% | -460.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 98.95% | 93.50% | 143.75% | -408.71% | -460.46% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -149.25% | 3.49% | 56.45% | -94.24% | 51.37% |
| Issuance of Common Stock | -43.09% | 16,722.51% | -99.91% | -84.67% | -99.79% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -1,091,090.00% | -- | -- | 100.00% |
| Cash from Financing | -47.64% | 17,099.96% | -107.47% | -109.20% | -99.79% |
| Foreign Exchange rate Adjustments | -99.18% | 99.40% | -377.93% | -1,026.41% | 298.85% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -67.87% | 459.40% | -57.20% | -87.33% | -110.40% |